Company Profile
Research and Development Laennec Regenerative Medicine Research Center
Vision
As a pharmaceutical company that handles human placental tissue in Japan, we aim to accurately understand the functions and characteristics of placental tissue and conduct research and development to help people lead healthy lives. In recent years, we have not only developed placenta extract, but also placenta-derived cells and extracellular matrix.
We are developing our own original products focusing on placenta-derived cells and extracellular matrix.
Research
Starting with placenta-derived extracellular matrix,
as a pharmaceutical manufacturer, we are conducting clinical research in collaboration with various university medical institutions and research institutes in Japan and overseas to contribute to the healing of symptoms and improvement of QOL by activating patients’ own cells and tissues using placenta-derived stem cells and miRNA contained in exosomes produced by the placenta.
Development
Using placenta-derived extracellular matrix, we are developing products such as next-generation medical devices and regenerative medicine.
We also develop cosmetics and supplements by applying the technologies obtained through these developments.
We extract various growth factors and cytokines produced by various cells of the placenta using our proprietary methods, and aim to develop reagents and other products that will contribute to the development of regenerative medicine and its research fields.
History
-
1958
Laennec approved by the competent authority
Developed by the late Professor Kentaro Hieda at the Kurume Tissue Regeneration Institute. -
Since 1974
JBP started production and sales
Inherited Laennec, a placenta-derived liver function improving drug. -
April 2004
Established Placenta-Aloe Research Institute (PARI)
JBP’s in-house research laboratory was established to clarify the mechanism of action of placenta extract and to discover and extract new ingredients from the placenta. The name was later changed to Placenta-Avenir Research Institute. -
April 2013
Established Technology Development Center (TDC)
Established to develop new products and improve existing products. -
January 2022
Established Laennec Regenerative Medicine Research Center (Re-Center)
Research Institute and Technology Development Center merged to provide new placenta value through product development.
Delivering the New Value of Placenta
In order to realize the ideal circulation and maintenance of “life” and “environment,” which is our management philosophy, through placenta, we will search for new ingredients and new ways of using placenta, leading to its practical application.
